The Marque The Marque

Reshma Kewalramani

CEO & President

Vertex Pharmaceuticals

Boston, MA, USA


Reshma Kewalramani
Bryan Kestner
Creator, Executive Producer & Entrepreneur
Rishi Khosla
OakNorth Bank

Reshma Kewalramani’s Biography

Reshma Kewalramani is the CEO and President of Vertex Pharmaceuticals. A highly experienced medical doctor, clinician, researcher, and nephrologist, she is well equipped to lead Vertex to its next stage of growth.

She previously held the positions of Executive Vice President, Chief Medical Officer and Senior Vice President. During her time at Vertex, the company has pioneered ground-breaking medical treatments for cystic fibrosis, namely SYMDEKO/SYMKEVI and TRIKAFTA/KAFTRIO, bringing these transformative new therapies to the majority of CF patients around the world.

Formerly, Dr. Kewalramani spent more than 12 years at Amgen in several senior roles, notably as Vice President, Head US Medical Organization. During this time, she expanded Amgen’s Research and Development unit and established the US Medical Organization which oversaw molecular responsibilities.

A passionate doctor, teacher, mentor, philanthropist and STEM advocate, Dr. Kewalramani is active in her community. Amongst many of her other roles and responsibilities, she is a Fellow of the American Society of Nephrology,...
Reshma Kewalramani is the CEO and President of Vertex Pharmaceuticals. A highly experienced medical doctor, clinician, researcher, and nephrologist, she is well equipped to lead Vertex to its next stage of growth.

She previously held the positions of Executive Vice President, Chief Medical Officer and Senior Vice President. During her time at Vertex, the company has pioneered ground-breaking medical treatments for cystic fibrosis, namely SYMDEKO/SYMKEVI and TRIKAFTA/KAFTRIO, bringing these transformative new therapies to the majority of CF patients around the world.

Formerly, Dr. Kewalramani spent more than 12 years at Amgen in several senior roles, notably as Vice President, Head US Medical Organization. During this time, she expanded Amgen’s Research and Development unit and established the US Medical Organization which oversaw molecular responsibilities.

A passionate doctor, teacher, mentor, philanthropist and STEM advocate, Dr. Kewalramani is active in her community. Amongst many of her other roles and responsibilities, she is a Fellow of the American Society of Nephrology, a board member of the Biomedical Science Careers Program, a member of the Dean’s Advisory Committee at Boston University Medical School, and a board member of RIZE Massachusetts.

Dr. Kewalramani completed her internship and residency at several Mass General Brigham medical centers, including as Resident Physician at Massachusetts General Hospital.

Throughout her notable career, she has earned several accolades, most recently as a leading CEO of a Fortune 500 biotech company and as an International Institute of New England Golden Door Award Honoree.

She is an alumnus of Harvard Business School and holds a Summa Cum Laude medical degree from Boston University School of Medicine.
READ MORE VIEW LESS

Reshma Kewalramani’s Background

Vertex Pharmaceuticals
CEO & President
Apr 2020 - Present
Boston, MA, USA
Vertex Pharmaceuticals is a leading biotechnology company that invests in scientific innovation to create transformative new medicines. Dr. Kewalramani previously served as the Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs from April 2018 through March 2020.
 
Amgen
Vice President, Head US Medical Organization
Jun 2004 - Jul 2017
Thousand Oaks, CA, USA
Dr. Kewalramani gained experience in several roles at Amgen, notably, Vice President, Head US Medical Organization; Vice Present, Head Nephrology and Metabolic Therapeutic Area, Global Clinical Development; and other various roles across Global Clinical Development and Medical Affairs.
 
View all Hide

Reshma Kewalramani’s Gallery

Board Positions

Ginkgo Bioworks, Inc.
Board Member
Aug 2021 - Present
Boston, MA, USA
Ginkgo Bioworks, a private analytics company, utilizes advanced technology to program cells to produce unique products across a range of industries.
 
Vertex Pharmaceuticals
Board Member
Apr 2020 - Present
Boston, MA, USA
 
View all Hide

Advisory Roles

Boston University School of Medicine
Advisory Board
Boston, MA, USA
She is a member of the Boston University Medical School's Dean's Advisory Committee. Her role is to assist the board on curricula and appointments made at the Medical School.
 

Previous Board Positions

Kidney Health Institute
Board Member
Boston, MA, USA
She was previously appointed to the inaugural Board of Directors at the Kidney Health Institute.
 

Media

Vertex's CF drugs drive 18% growth as company looks to diversify
Quoted
Jul 2021
Reshma is quoted in this article that discusses Vertex's significant growth and internal investment strategy. "You have never seen us invest more in our internal innovation," she says.
 
Meet the new Fortune 500 CEO's
Mentioned
Jun 2021
New York, NY, USA
She is mentioned on Fortune's list of the 500 new CEOs for her position at Vertex Pharmaceuticals.
 

Interviews

Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories?
May 2021
Dr. Kewalramani discusses the difficulties in her first days as CEO of Vertex in the middle of a global pandemic, as well as her plans for the company's success in the future.
 
Diversity in Action: Q&A With Reshma Kewalramani
Jul 2022
In this Q&A with Barri Blauvelt, Reshma speaks on the ways that companies can work to make gender and diversity gaps smaller in STEM, as well as Vertex's solutions to promoting diversity and investing into the next generation of scientists.
 
View all Hide

Features

Reshma Kewalramani: 'It's about raising your hand, raising your voice'
Dec 2020
She is profiled in honor of her 2020 Boston Business Journal Woman Who Mean Business award.
 

Awards & Recognition

STATUS List logo STATUS List logo
STATUS List
Honoree
2023
Boston, MA, USA
The STAT Status List is a ranking published by STAT News that highlights influential leaders and rising stars in the life sciences, healthcare, and biotech industries. It serves as a curated guide to individuals making significant impacts in these fields, recognizing innovators, policy leaders, and emerging talent shaping the future of health and medicine.
 
Babson College
Honorary Doctor of Humane Letters degree
May 2023
Wellesley, MA, USA
Reshma was awarded an Honorary Doctor of Human Letters for her outstanding contribution to the entrepreneurial community by Babson College.
 
View all Hide

Training & Management Courses

Harvard Business School Executive Education
Training and Management
Boston, MA, USA
The General Management Program offers a multi-faceted approach to executive business leadership, offering students innovative approaches to business in the 21st century.
 

Speaking Engagements

2021 Effective Practices Conference
Keynote Speaker
Dec 2021
Dr. Kewalramani will give the keynote address for the 2021 Effective Practices Conference to discuss the advancements and opportunities given to women at Vertex as well as ways in which other companies can continue to work towards gender equality in the workforce.
 

Press Releases

Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors
Featured
Aug 2021
She has been named a new member for Ginkgo Bioworks' Board of Directors in recognition for her expertise and dedication to innovating the industry and educating the future generation of scientists.
 

Fellowships

American Society of Nephrology
Fellow
Washington, DC, USA
She is board certified in internal medicine and nephrology with The American Society of Nephrology.
 

Reshma Kewalramani’s Education

Boston University School of Medicine
Doctor of Medicine (M.D)/ Summa Cum Laude
1990 - 1998
Boston University
Liberal Arts/Medical Education Program; Doctor of Medicine (M.D)
1990 - 1998
View allHide